Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hugh Barrett

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Kinetics

Disorders

Anatomy

Liver

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
67
Watts, Gerald
53
Chan, Dick
18
Huff, Murray
15
Ooi, Esther
15
Parhofer, Klaus
15
Redgrave, Trevor
14
Schaefer, Ernst
14
Burnett, John
14
Dolnikowski, Gregory
12
Telford, Dawn
11
Welty, Francine
9
Ng, Theodore
9
Lichtenstein, Alice
9
Mamo, John
8
Rye, Kerry-Anne

Sign-in to see all Coauthors

Publications

TOP 3
Ng Theodore W K; Chan Dick C; Barrett P Hugh R; Watts Gerald F
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Chan Dick C; Lambert Gilles; Barrett P Hugh R; Rye Kerry-Anne; Ooi Esther M M; Watts Gerald F
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?
Chan Dick C; Watts Gerald F; Ooi Esther M M; Rye Kerry-Anne; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hugh Barrett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Ng Theodore W K; Chan Dick C; Barrett P Hugh R; Watts Gerald F
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Clinical science (London, England : 1979) 2010;118(1):79-85.
2009: Chan Dick C; Lambert Gilles; Barrett P Hugh R; Rye Kerry-Anne; Ooi Esther M M; Watts Gerald F
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?
Clinical chemistry 2009;55(11):2049-52.
2009: Chan Dick C; Watts Gerald F; Ooi Esther M M; Rye Kerry-Anne; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.
Diabetes care 2009;32(11):2111-3.
2009: Chan Dick C; Barrett P Hugh R; Ooi Esther M M; Ji Juying; Chan Doris T; Watts Gerald F
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
The Journal of clinical endocrinology and metabolism 2009;94(3):989-97.
2008: Chan D C; Watts G F; Ng T W K; Yamashita S; Barrett P H R
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
European journal of clinical investigation 2008;38(10):743-51.
2008: Matthan Nirupa R; Jalbert Susan M; Barrett P Hugh R; Dolnikowski Gregory G; Schaefer Ernst J; Lichtenstein Alice H
Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1838-43.
2008: Allister Emma M; Mulvihill Erin E; Barrett P Hugh R; Edwards Jane Y; Carter Lindsey P; Huff Murray W
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
Journal of lipid research 2008;49(10):2218-29.
2008: Chan Dick C; Watts Gerald F; Ooi Esther M M; Ji Juying; Johnson Anthony G; Barrett P Hugh R
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1831-7.
2008: Lamon-Fava Stefania; Diffenderfer Margaret R; Barrett P Hugh R; Buchsbaum Aaron; Nyaku Mawuli; Horvath Katalin V; Asztalos Bela F; Otokozawa Seiko; Ai Masumi; Matthan Nirupa R; Lichtenstein Alice H; Dolnikowski Gregory G; Schaefer Ernst J
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(9):1672-8.
2008: Watts Gerald F; Barrett P Hugh R; Chan Dick C
HDL metabolism in context: looking on the bright side.
Current opinion in lipidology 2008;19(4):395-404.
2008: Ooi Esther M M; Watts Gerald F; Chan Dick C; Chen Meifania M; Nestel Paul J; Sviridov Dmitri; Barrett P Hugh R
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.
Diabetes care 2008;31(8):1656-61.
2008: Chan Dick C; Watts Gerald F; Wang Jian; Hegele Robert A; van Bockxmeer Frank M; Barrett P Hugh R
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
Clinical endocrinology 2008;69(1):45-51.
2008: Ooi Esther M M; Barrett P Hugh R; Chan Dick C; Watts Gerald F
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
Clinical science (London, England : 1979) 2008;114(10):611-24.
2008: Sviridov Dmitri; Hoang Anh; Ooi Esther; Watts Gerald; Barrett P H R; Nestel Paul
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.
Atherosclerosis 2008;197(2):732-9.
2008: Millar John S; Brousseau Margaret E; Diffenderfer Margaret R; Barrett P Hugh R; Welty Francine K; Cohn Jeffrey S; Wilson Aisha; Wolfe Megan L; Nartsupha Chorthip; Schaefer Peter M; Digenio Andres G; Mancuso James P; Dolnikowski Gregory G; Schaefer Ernst J; Rader Daniel J
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
Journal of lipid research 2008;49(3):543-9.
2008: Ooi Esther M M; Barrett P Hugh R; Chan Dick C; Nestel Paul J; Watts Gerald F
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
Atherosclerosis 2008;197(1):139-46.
2008: Ooi Esther M M; Watts Gerald F; Nestel Paul J; Sviridov Dmitri; Hoang Anh; Barrett P Hugh R
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2008;93(2):430-7.
2008: Chan Dick C; Nguyen Minh N; Watts Gerald F; Barrett P Hugh R
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
The Journal of clinical endocrinology and metabolism 2008;93(2):557-64.
2007: Gibbons Peter L; Batty Kevin T; Barrett P Hugh R; Davis Timothy M E; Ilett Kenneth F
Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.
International journal for parasitology 2007;37(14):1569-76.
2007: Ng Theodore W K; Watts Gerald F; Barrett P Hugh R; Rye Kerry-Anne; Chan Dick C
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
Diabetes care 2007;30(11):2945-50.
2007: Burnett John R; Zhong Shumei; Jiang Zhenghui G; Hooper Amanda J; Fisher Eric A; McLeod Roger S; Zhao Yang; Barrett P Hugh R; Hegele Robert A; van Bockxmeer Frank M; Zhang Hongyu; Vance Dennis E; McKnight C James; Yao Zemin
Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
The Journal of biological chemistry 2007;282(33):24270-83.
2007: Lamon-Fava Stefania; Diffenderfer Margaret R; Barrett P Hugh R; Buchsbaum Aaron; Matthan Nirupa R; Lichtenstein Alice H; Dolnikowski Gregory G; Horvath Katalin; Asztalos Bela F; Zago Valeria; Schaefer Ernst J
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism.
Journal of lipid research 2007;48(8):1746-53.
2007: Goucke C Roger; Hackett L Peter; Barrett P Hugh; Ilett Kenneth F
Blood concentrations of enflurane before, during, and after hypothermic cardiopulmonary bypass.
Journal of cardiothoracic and vascular anesthesia 2007;21(2):218-23.
2007: Hooper Amanda J; Robertson Ken; Barrett P Hugh R; Parhofer Klaus G; van Bockxmeer Frank M; Burnett John R
Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
The Journal of clinical endocrinology and metabolism 2007;92(4):1474-8.
2007: Telford Dawn E; Sutherland Brian G; Edwards Jane Y; Andrews Joseph D; Barrett P Hugh R; Huff Murray W
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.
Journal of lipid research 2007;48(3):699-708.
2007: Ooi Esther M M; Watts Gerald F; Barrett P Hugh R; Chan Dick C; Clifton Peter M; Ji Juying; Nestel Paul J
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Asia Pacific journal of clinical nutrition 2007;16(4):624-31.
2006: Ooi Esther M M; Watts Gerald F; Ji Juying; Rye Kerry-Anne; Johnson Anthony G; Chan Dick C; Barrett P Hugh R
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
Clinical endocrinology 2006;65(6):752-9.
2006: Chan D C; Watts G F; Ng T W K; Hua J; Song S; Barrett P H R
Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.
Diabetes, obesity & metabolism 2006;8(6):698-702.
2006: Watts G F; Chan D C; Ooi E M M; Nestel P J; Beilin L J; Barrett P H R
Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
Clinical and experimental pharmacology & physiology 2006;33(9):877-82.
2006: Ooi E M M; Watts G F; Farvid M S; Chan D C; Allen M C; Zilko S R; Barrett P H R
High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
European journal of clinical investigation 2006;36(9):626-32.
2006: Watts Gerald F; Ji Juying; Chan Dick C; Ooi Esther M M; Johnson Anthony G; Rye Kerry-Anne; Barrett P Hugh R
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Clinical science (London, England : 1979) 2006;111(3):193-9.
2006: Davis Timothy M E; Hamzah Juliana; Ilett Kenneth F; Karunajeewa Harin A; Reeder John C; Batty Kevin T; Hackett Sara; Barrett P Hugh R
In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs.
Antimicrobial agents and chemotherapy 2006;50(8):2883-5.
2006: Barrett P Hugh R; Chan Dick C; Watts Gerald F
Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.
Journal of lipid research 2006;47(8):1607-19.
2006: Parhofer Klaus G; Barrett P Hugh R
Thematic review series: patient-oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies.
Journal of lipid research 2006;47(8):1620-30.
2006: Chan Dick C; Watts Gerald F; Nguyen Minh N; Barrett P Hugh R
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.
The American journal of clinical nutrition 2006;84(1):37-43.
2006: Allister E M; James A P; Watts G F; Barrett P H R; Mamo J C L
Effect of an acute hyperinsulinaemic clamp on post-prandial lipaemia in subjects with insulin resistance.
European journal of clinical investigation 2006;36(7):489-96.
2006: Millar John S; Brousseau Margaret E; Diffenderfer Margaret R; Barrett P Hugh R; Welty Francine K; Faruqi Aisha; Wolfe Megan L; Nartsupha Chorthip; Digenio Andres G; Mancuso James P; Dolnikowski Gregory G; Schaefer Ernst J; Rader Daniel J
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(6):1350-6.
2006: Nguyen Minh N; Chan Dick C; Dwyer Kevin P; Bolitho Paul; Watts Gerald F; Barrett P Hugh R
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma.
Journal of lipid research 2006;47(6):1274-80.
2006: Dinkel Regina E; Barrett P Hugh R; Demant Thomas; Parhofer Klaus G
In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16(3):215-21.
2006: Kee P; Caiazza D; Rye K-A; Barrett P H R; Morehouse L A; Barter P J
Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(4):884-90.
2006: Chan Dick C; Watts Gerald F; Nguyen Minh N; Barrett P Hugh R
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):590-6.
2006: Ji Juying; Watts Gerald F; Johnson Anthony G; Chan Dick C; Ooi Esther M M; Rye Kerry-Anne; Serone Adrian P; Barrett P Hugh R
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
The Journal of clinical endocrinology and metabolism 2006;91(3):973-9.
2006: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders.
Current opinion in lipidology 2006;17(1):28-36.
2006: Lamon-Fava Stefania; Postfai Borbala; Diffenderfer Margaret; DeLuca Carl; O'Connor John; Welty Francine K; Dolnikowski Gregory G; Barrett P Hugh R; Schaefer Ernst J
Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):385-91.
2005: Burnett John R; Telford Dawn E; Barrett P Hugh R; Huff Murray W
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Biochimica et biophysica acta 2005;1738(1-3):10-8.
2005: Ng T W K; Watts G F; Stuckey B G A; Ching H L; Chan D C F; Uchida Y; Sakai N; Yamashita S; Martins I J; Redgrave T G; Barrett P H R
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Clinical endocrinology 2005;63(6):650-6.
2005: Telford Dawn E; Lipson Sara M; Barrett P Hugh R; Sutherland Brian G; Edwards Jane Y; Aebi Johannes D; Dehmlow Henrietta; Morand Olivier H; Huff Murray W
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2608-14.
2005: Chan Dick C; Watts Gerald F; Ng Theodore W K; Uchida Yoshiaki; Sakai Naohiko; Yamashita Shizuya; Barrett P Hugh R
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Clinical biochemistry 2005;38(9):806-12.
2005: Farvid M S; Ng T W K; Chan D C; Barrett P H R; Watts G F
Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia.
Diabetes, obesity & metabolism 2005;7(4):406-13.
2005: Ooi Esther M M; Watts Gerald F; Farvid Maryam S; Chan Dick C; Allen Michael C; Zilko Simon R; Barrett P Hugh R
High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Obesity research 2005;13(6):1008-16.
2005: Jenner Jennifer L; Seman Leo J; Millar John S; Lamon-Fava Stefania; Welty Francine K; Dolnikowski Gregory G; Marcovina Santica M; Lichtenstein Alice H; Barrett P Hugh R; deLuca Carl; Schaefer Ernst J
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
Metabolism: clinical and experimental 2005;54(3):361-9.
2005: Ng Theodore W K; Watts Gerald F; Farvid Maryam S; Chan Dick C; Barrett P Hugh R
Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
Diabetes 2005;54(3):795-802.
2005: Chan Dick C; Watts Gerald F; Ng Theodore W K; Uchida Yoshiaki; Sakai Naohiko; Yamashita Shizuya; Barrett P Hugh R
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
Clinical chemistry 2005;51(3):578-85.
2005: Millar John S; Maugeais Cyrille; Ikewaki Katsunori; Kolansky Daniel M; Barrett P Hugh R; Budreck Elaine C; Boston Raymond C; Tada Norio; Mochizuki Seibu; Defesche Joep C; Wilson James M; Rader Daniel J
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(3):560-5.
2005: Whitfield Amanda J; Barrett P Hugh R; Robertson Ken; Havlat Marek F; van Bockxmeer Frank M; Burnett John R
Liver dysfunction and steatosis in familial hypobetalipoproteinemia.
Clinical chemistry 2005;51(1):266-9.
2004: O'Brien Kevin D; Lewis Katherine; Fischer Jens W; Johnson Pamela; Hwang Jin-Yong; Knopp Eleanor A; Kinsella Michael G; Barrett P Hugh R; Chait Alan; Wight Thomas N
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis.
Atherosclerosis 2004;177(1):29-35.
2004: Chan D C; Watts G F; Barrett P H R; Whitfield A J; van Bockxmeer F M
ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(11):2188-91.
2004: Whitfield Amanda J; Barrett P Hugh R; van Bockxmeer Frank M; Burnett John R
Lipid disorders and mutations in the APOB gene.
Clinical chemistry 2004;50(10):1725-32.
2004: Welty Francine K; Lichtenstein Alice H; Barrett P Hugh R; Dolnikowski Gregory G; Schaefer Ernst J
Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1703-7.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
Clinical science (London, England : 1979) 2004;107(3):233-49.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.
Clinical science (London, England : 1979) 2004;107(3):221-32.
2004: Karunajeewa Harin A; Ilett Kenneth F; Dufall Kitiya; Kemiki Adedayo; Bockarie Moses; Alpers Michael P; Barrett P Hugh; Vicini Paolo; Davis Timothy M E
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
Antimicrobial agents and chemotherapy 2004;48(8):2966-72.
2004: Geiss H C; Bremer S; Barrett P H R; Otto C; Parhofer K G
In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis.
Journal of lipid research 2004;45(8):1459-67.
2004: Matthan Nirupa R; Welty Francine K; Barrett P Hugh R; Harausz Carrie; Dolnikowski Gregory G; Parks John S; Eckel Robert H; Schaefer Ernst J; Lichtenstein Alice H
Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(6):1092-7.
2004: Tannock L R; Little P J; Tsoi C; Barrett P H R; Wight T N; Chait A
Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.
Diabetologia 2004;47(5):837-43.
2004: Prinsen Berthil H C M T; Rabelink Ton J; Romijn Johannes A; Bisschop Peter H; de Barse Martina M J; de Boer José; van Haeften Timon W; Barrett P Hugh R; Berger Ruud; de Sain-van der Velden Monique G M
A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
Kidney international 2004;65(3):1064-75.
2004: Chan Dick C; Barrett P Hugh R; Watts Gerald F
Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004;25(1):31-48.
2004: Chan Dick C; Watts Gerald F; Sussekov Andrei V; Barrett P Hugh R; Yang Zhaojun; Hua Jianmin; Song Swithin
Adipose tissue compartments and insulin resistance in overweight-obese Caucasian men.
Diabetes research and clinical practice 2004;63(2):77-85.
2003: Whitfield A J; Marais A D; Robertson K; Barrett P H R; van Bockxmeer F M; Burnett J R
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
Human mutation 2003;22(2):178.
2003: Watts G F; Chan D C; Barrett P H R; O'Neill F H; Thompson G R
Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(7):862-5.
2003: Prinsen Berthil H C M T; Romijn Johannes A; Bisschop Peter H; de Barse Martina M J; Barrett P Hugh R; Ackermans Mariëtte; Berger Ruud; Rabelink Ton J; de Sain-van der Velden Monique G M
Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans.
Journal of lipid research 2003;44(7):1341-8.
2003: Chan D C; Watts G F; Barrett P H R; Burke V
Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men.
QJM : monthly journal of the Association of Physicians 2003;96(6):441-7.
2003: Parhofer Klaus G; Laubach Ester; Barrett P Hugh R
Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.
Journal of lipid research 2003;44(6):1192-8.
2003: Hegele Robert A; Zinman Bernard; Hanley Anthony J G; Harris Stewart B; Barrett P Hugh; Cao Henian
Genes, environment and Oji-Cree type 2 diabetes.
Clinical biochemistry 2003;36(3):163-70.
2003: Chan D C; Watts G F; Barrett P H R
Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
Diabetes, obesity & metabolism 2003;5(3):202-6.
2003: Telford Dawn E; Edwards Jane Y; Lipson Sara M; Sutherland Brian; Barrett P Hugh R; Burnett John R; Krul Elaine S; Keller Bradley T; Huff Murray W
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.
Journal of lipid research 2003;44(5):943-52.
2003: Chan Dick C; Watts Gerald F; Barrett P Hugh R; O'Neill Frans H; Thompson Gilbert R
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Obesity research 2003;11(4):591-6.
2003: Davis Timothy M E; Syed David A; Ilett Kenneth F; Barrett P Hugh R
Toxicity related to chloroquine treatment of resistant vivax malaria.
The Annals of pharmacotherapy 2003;37(4):526-9.
2003: Chan Dick C; Watts Gerald F; Barrett P Hugh R; O'Neill Frans H; Redgrave Trevor G; Thompson Gilbert R
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
Clinical science (London, England : 1979) 2003;104(4):383-8.
2003: Dane-Stewart C A; Watts G F; Barrett P H R; Stuckey B G A; Mamo J C L; Martins I J; Redgrave T G
Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Clinical endocrinology 2003;58(4):415-20.
2003: Ching H L; Watts G F; Dhaliwal S S; Barrett P H R; Stuckey B G A
Vascular function of forearm microcirculation in postmenopausal women with type 2 diabetes: potential benefit of hormone replacement therapy?
Climacteric : the journal of the International Menopause Society 2003;6(1):31-7.
2003: Watts Gerald F; Barrett P Hugh R; Ji Juying; Serone Adrian P; Chan Dick C; Croft Kevin D; Loehrer Franziska; Johnson Anthony G
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Diabetes 2003;52(3):803-11.
2003: James Anthony P; Watts Gerald F; Barrett P Hugh R; Smith Darrin; Pal Sebely; Chan Dick C; Mamo John C L
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men.
Metabolism: clinical and experimental 2003;52(2):136-41.
2003: Borradaile Nica M; de Dreu Linda E; Barrett P Hugh R; Behrsin Colleen D; Huff Murray W
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
Biochemistry 2003;42(5):1283-91.
2003: Barrett P Hugh R; Watts Gerald F
Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.
Current opinion in lipidology 2003;14(1):61-8.
2003: Chan Dick C; Watts Gerald F; Mori Trevor A; Barrett P Hugh R; Redgrave Trevor G; Beilin Lawrence J
Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
The American journal of clinical nutrition 2003;77(2):300-7.
2003: Watts Gerald F; Chan Dick C; Barrett P Hugh R; Susekov Andrei V; Hua Jianmin; Song Swithin
Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Obesity research 2003;11(1):152-9.
2002: Rashid Shirya; Uffelman Kristine D; Barrett P Hugh R; Lewis Gary F
Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
Circulation 2002;106(23):2955-60.
2002: Kee Patrick; Rye Kerry-Anne; Taylor John L; Barrett P Hugh R; Barter Philip J
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1912-7.
2002: Huff Murray W; Telford Dawn E; Edwards Jane Y; Burnett John R; Barrett P Hugh R; Rapp Stephen R; Napawan Nida; Keller Bradley T
Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1884-91.
2002: Olin-Lewis Katherine; Krauss Ronald M; La Belle Michael; Blanche Patricia J; Barrett P Hugh R; Wight Thomas N; Chait Alan
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan.
Journal of lipid research 2002;43(11):1969-77.
2002: Prinsen Berthil H C M T; Kaysen George A; Klomp Leo W J; de Boer Jose; Barrett P Hugh R; Thornalley Paul J; Battah Sinan; Berger Ruud; Rabelink Ton J; de Sain-van der Velden Monique G M
Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate.
Clinical biochemistry 2002;35(7):545-53.
2002: Borradaile Nica M; de Dreu Linda E; Barrett P Hugh R; Huff Murray W
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Journal of lipid research 2002;43(9):1544-54.
2002: Cohn Jeffrey S; Tremblay Michel; Batal Rami; Jacques Hélène; Veilleux Lyne; Rodriguez Claudia; Barrett P Hugh R; Dubreuil Denise; Roy Madeleine; Bernier Lise; Mamer Orval; Davignon Jean
Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia.
Journal of lipid research 2002;43(9):1464-71.
2002: Watts Gerald F; Chan Dick C; Barrett P Hugh R
Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Metabolism: clinical and experimental 2002;51(9):1206-10.
2002: Chan Dick C; Watts Gerald F; Redgrave Trevor G; Mori Trevor A; Barrett P Hugh R
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Metabolism: clinical and experimental 2002;51(8):1041-6.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Beilin Lawrence J; Redgrave Trevor G; Mori Trevor A
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Diabetes 2002;51(8):2377-86.
2002: Davis Timothy M E; Binh Tran Quang; Thu Le Thi Anh; Long Ton That Ai; Johnston Wayne; Robertson Ken; Barrett P Hugh R
Glucose and lactate turnover in adults with falciparum malaria: effect of complications and antimalarial therapy.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2002;96(4):411-7.
2002: Dane-Stewart C A; Watts G F; Mamo J C L; Barrett P H R; Martins I J; Dimmitt S B; Redgrave T G
Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
European journal of clinical investigation 2002;32(7):493-9.
2002: Chan D C; Watts G F; Mori T A; Barrett P H R; Beilin L J; Redgrave T G
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity.
European journal of clinical investigation 2002;32(6):429-36.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Beilin Lawrence J; Mori Trevor A
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity.
Clinical chemistry 2002;48(6 Pt 1):877-83.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Mori Trevor A; Beilin Lawrence J; Redgrave Trevor G
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
The Journal of clinical endocrinology and metabolism 2002;87(5):2283-9.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh R; Martins Ian J; James Anthony P; Mamo John C L; Mori Trevor A; Redgrave Trevor G
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Journal of lipid research 2002;43(5):706-12.
2002: Triggs-Raine Barbara L; Kirkpatrick Robert D; Kelly Sherrie L; Norquay Lisa D; Cattini Peter A; Yamagata Kazuya; Hanley Anthony J G; Zinman Bernard; Harris Stewart B; Barrett P Hugh; Hegele Robert A
HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4614-9.
2002: Barrett P Hugh R; Watts Gerald F
Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism.
Atherosclerosis. Supplements 2002;2(3):1-4.
2002: Rashid Shirya; Barrett P Hugh R; Uffelman Kristine D; Watanabe Takehiko; Adeli Khosrow; Lewis Gary F
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(3):483-7.
2002: Watts G F; Barrett P H
High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2002;12(1):36-41.
2002: Dwyer Kevin P; Barrett P Hugh R; Chan Dick; Foo Jock I; Watts Gerald F; Croft Kevin D
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins.
Journal of lipid research 2002;43(2):344-9.
2002: Chan Dick C; Watts Gerald F; Barrett P Hugh; Mamo John C L; Redgrave Trevor G
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Clinical chemistry 2002;48(2):278-83.
2002: Tannock Lisa R; Olin Katherine L; Barrett P Hugh R; Wight Thomas N; Chait Alan
Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan.
The Journal of clinical endocrinology and metabolism 2002;87(1):35-40.
2002: Burnett John R; Barrett P Hugh R
Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies.
Critical reviews in clinical laboratory sciences 2002;39(2):89-137.
2001: Watts G F; Chan D C; Barrett P H; Martins I J; Redgrave T G
Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Clinical science (London, England : 1979) 2001;101(6):683-90.
2001: Barrett P H; Watts G F
HDL kinetics, fish oils and diabetes.
Atherosclerosis 2001;159(1):243-4.
2001: Huggins K W; Colvin P L; Burleson E R; Kelley K; Sawyer J K; Barrett P H; Rudel L L; Parks J S
Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys.
Journal of lipid research 2001;42(9):1457-66.
2001: Mamo J C; Watts G F; Barrett P H; Smith D; James A P; Pal S
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
American journal of physiology. Endocrinology and metabolism 2001;281(3):E626-32.
2001: Dogra G; Ward N; Croft K D; Mori T A; Barrett P H; Herrmann S E; Irish A B; Watts G F
Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1626-30.
2001: Watts G F; Barrett P H; Marais A D; Dane-Stewart C A; Martins I J; Dimmitt S B; Redgrave T G
Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Atherosclerosis 2001;157(2):519-23.
2001: Carr M C; Hokanson J E; Zambon A; Deeb S S; Barrett P H; Purnell J Q; Brunzell J D
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
The Journal of clinical endocrinology and metabolism 2001;86(6):2831-7.
2001: Redgrave T G; Watts G F; Martins I J; Barrett P H; Mamo J C; Dimmitt S B; Marais A D
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Journal of lipid research 2001;42(5):710-5.
2001: Rashid S; Uffelman K D; Barrett P H; Vicini P; Adeli K; Lewis G F
Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits.
Journal of lipid research 2001;42(2):265-71.
2001: Dane-Stewart C A; Watts G F; Mamo J C; Dimmitt S B; Barrett P H; Redgrave T G
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
European journal of clinical investigation 2001;31(2):113-7.
2001: Olin K L; Potter-Perigo S; Barrett P H; Wight T N; Chait A
Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(1):129-35.
2000: Parhofer K G; Barrett P H; Schwandt P
Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
The Journal of clinical endocrinology and metabolism 2000;85(11):4224-30.
2000: Davis T M; Binh T Q; Thu L T; Rossi R; Danh P T; Barrett P H; Beilby J
Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria.
Clinical science (London, England : 1979) 2000;99(5):433-41.
2000: Parhofer K G; Barrett P H; Demant T; Schwandt P
Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B.
Journal of lipid research 2000;41(10):1596-603.
2000: Watts G F; Moroz P; Barrett P H
Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
Metabolism: clinical and experimental 2000;49(9):1204-10.
2000: Welty F K; Lichtenstein A H; Barrett P H; Jenner J L; Dolnikowski G G; Schaefer E J
Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1807-10.
2000: Batal R; Tremblay M; Barrett P H; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn J S
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Journal of lipid research 2000;41(5):706-18.
2000: Davis T M; Daly F; Walsh J P; Ilett K F; Beilby J P; Dusci L J; Barrett P H
Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.
British journal of clinical pharmacology 2000;49(3):223-30.
2000: Wolfe B M; Barrett P H; Laurier L; Huff M W
Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women.
Journal of lipid research 2000;41(3):368-75.
2000: Twisk J; Gillian-Daniel D L; Tebon A; Wang L; Barrett P H; Attie A D
The role of the LDL receptor in apolipoprotein B secretion.
The Journal of clinical investigation 2000;105(4):521-32.
1999: Welty F K; Lichtenstein A H; Barrett P H; Dolnikowski G G; Schaefer E J
Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2966-74.
1999: Olin K L; Potter-Perigo S; Barrett P H; Wight T N; Chait A
Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells.
The Journal of biological chemistry 1999;274(49):34629-36.
1999: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Endocrinology 1999;140(11):5293-302.
1999: Colvin P L; Moriguchi E; Barrett P H; Parks J S; Rudel L L
Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates.
Journal of lipid research 1999;40(10):1782-92.
1999: Vélez-Carrasco W; Lichtenstein A H; Barrett P H; Sun Z; Dolnikowski G G; Welty F K; Schaefer E J
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
Journal of lipid research 1999;40(9):1695-700.
1999: Sumner A E; Falkner B; Diffenderfer M R; Barrett P H; Marsh J B
A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1999;221(4):352-60.
1999: Riches F M; Watts G F; Hua J; Stewart G R; Naoumova R P; Barrett P H
Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
The Journal of clinical endocrinology and metabolism 1999;84(8):2854-61.
1999: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Journal of lipid research 1999;40(7):1317-27.
1999: Wilcox L J; Barrett P H; Huff M W
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Journal of lipid research 1999;40(6):1078-89.
1999: Parhofer K G; Barrett P H; Schwandt P
Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters.
Atherosclerosis 1999;144(1):159-66.
1999: Lamarche B; Uffelman K D; Carpentier A; Cohn J S; Steiner G; Barrett P H; Lewis G F
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.
The Journal of clinical investigation 1999;103(8):1191-9.
1999: Wilcox L J; Barrett P H; Newton R S; Huff M W
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):939-49.
1998: Burnett J R; Barrett P H; Vicini P; Miller D B; Telford D E; Kleinstiver S J; Huff M W
The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(12):1906-14.
1998: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Huff M W
Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Biochimica et biophysica acta 1998;1393(1):63-79.
1998: Lamarche B; Uffelman K D; Steiner G; Barrett P H; Lewis G F
Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.
Journal of lipid research 1998;39(6):1162-72.
1998: Barrett P H; Bell B M; Cobelli C; Golde H; Schumitzky A; Vicini P; Foster D M
SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.
Metabolism: clinical and experimental 1998;47(4):484-92.
1998: Barrett P H; Parhofer K G
Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.
Metabolism: clinical and experimental 1998;47(4):478-83.
1998: Vicini P; Barrett P H; Cobelli C; Foster D M; Schumitzky A
Approaches to population kinetic analysis with application to metabolic studies.
Advances in experimental medicine and biology 1998;445():103-13.
1997: Burnett J R; Wilcox L J; Telford D E; Kleinstiver S J; Barrett P H; Newton R S; Huff M W
Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2589-600.
1997: Lewis G F; Lamarche B; Uffelman K D; Heatherington A C; Honig M A; Szeto L W; Barrett P H
Clearance of postprandial and lipolytically modified human HDL in rabbits and rats.
Journal of lipid research 1997;38(9):1771-8.
1997: Welty F K; Lichtenstein A H; Barrett P H; Dolnikowski G G; Ordovas J M; Schaefer E J
Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
Journal of lipid research 1997;38(8):1535-43.
1997: Welty F K; Lichtenstein A H; Barrett P H; Dolnikowski G G; Ordovas J M; Schaefer E J
Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):881-8.
1996: Parhofer K G; Barrett P H; Demant T; Richter W O; Schwandt P
Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia.
Journal of lipid research 1996;37(11):2383-93.
1996: Parhofer K G; Barrett P H; Aguilar-Salinas C A; Schonfeld G
Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes.
Journal of lipid research 1996;37(4):844-52.
1995: Kushwaha R S; Barrett P H; Reardon C A; Lewis D S; Carey K D; Getz G S; McGill H C
Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
Metabolism: clinical and experimental 1995;44(8):1058-66.
1995: Aguilar-Salinas C A; Barrett P H; Parhofer K G; Young S G; Tessereau D; Bateman J; Quinn C; Schonfeld G
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(1):71-80.
1995: Aguilar-Salinas C A; Barrett P H; Kelber J; Delmez J; Schonfeld G
Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
Journal of lipid research 1995;36(1):188-99.
1994: Huff M W; Telford D E; Barrett P H; Billheimer J T; Gillies P J
Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1498-508.
1993: Foster D M; Barrett P H; Toffolo G; Beltz W F; Cobelli C
Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.
Journal of lipid research 1993;34(12):2193-205.
1993: Parhofer K G; Barrett P H; Dunn J; Schonfeld G
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.
The Clinical investigator 1993;71(11):939-46.
1992: Huff M W; Telford D E; Barrett P H
Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):902-10.
1992: Krul E S; Parhofer K G; Barrett P H; Wagner R D; Schonfeld G
ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies.
Journal of lipid research 1992;33(7):1037-50.
1992: Parhofer K G; Barrett P H; Bier D M; Schonfeld G
Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo.
The Journal of clinical investigation 1992;89(6):1931-7.
1992: Barrett P H; Parhofer K G; Schonfeld G
Postmenopausal estrogen and the metabolism of plasma lipoproteins.
The New England journal of medicine 1992;326(14):954-5.
1991: Barrett P H; Baker N; Nestel P J
Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
Journal of lipid research 1991;32(5):743-62.
1991: Kushwaha R S; Foster D M; Barrett P H; Carey K D; Bernard M G
Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp).
Metabolism: clinical and experimental 1991;40(1):93-100.
1990: Kushwaha R S; Foster D M; Barrett P H; Carey K D
Effect of estrogen and progesterone on metabolism of apoprotein B in baboons.
The American journal of physiology 1990;258(1 Pt 1):E172-83.

Sign-in to see more